SMED · Sharps Compliance Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Revenue | $76.42M | $51.15M | - | $33.38M | $38.19M | $33.38M |
| Cost of Revenue | $47.51M | $35.38M | $28.74M | $28.74M | $26.35M | $22.27M |
| Gross Profit | $28.91M | $15.76M | $13.27M | $11.40M | $11.84M | $11.11M |
| R&D | $100.0K | $100.0K | $100.0K | $100.0K | - | - |
| SG&A | $15.76M | $14.05M | $12.00M | $11.17M | $12.22M | $10.81M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $1.99M | $1.61M | $1.66M | $1.56M | $1.49M | $816.0K |
| Operating Income | $12.30M | $910.0K | $447.0K | ($577.0K) | ($1.19M) | $5.0K |
| Interest Expense | $194.0K | $127.0K | $87.0K | $94.0K | $0 | - |
| Income Tax | $1.47M | ($1.58M) | $170.0K | $21.0K | - | $24.0K |
| Net Income | $12.87M | $2.27M | $214.0K | ($672.0K) | ($1.29M) | $13.0K |
| EPS - Basic | $0.14 | - | - | - | ($0.08) | $0.00 |
| EPS - Diluted | $0.14 | - | - | - | ($0.08) | $0.00 |
Balance Sheet
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $27.77M | $5.42M | $12.44M | $15.16M | $4.67M | $12.44M |
| Accounts Receivable | $9.74M | $11.79M | $9.29M | $6.37M | $7.55M | $5.81M |
| Inventory | $6.11M | $5.64M | $3.77M | $3.99M | $4.10M | $3.92M |
| Accounts Payable | $2.92M | $3.29M | $2.95M | $1.50M | $1.71M | $1.62M |
| Current Assets | $45.10M | $24.29M | $18.75M | $16.25M | $17.02M | $22.86M |
| Total Assets | $75.43M | $54.14M | $36.04M | $33.23M | $34.46M | $30.15M |
| Current Liabilities | $17.15M | $13.24M | $8.18M | $5.99M | $6.53M | $5.63M |
| Long-term Debt | $3.33M | $3.50M | $948.0K | $1.47M | $2.00M | - |
| Total Liabilities | $28.85M | $24.56M | $9.91M | $8.06M | $9.18M | $6.30M |
| Stockholders' Equity | $46.58M | $29.58M | $26.13M | $25.17M | $25.29M | $23.84M |
| Retained Earnings | $13.63M | $761.0K | ($1.50M) | ($2.06M) | ($1.39M) | ($92.0K) |
Cash Flow
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $21.96M | $692.0K | $925.0K | $2.37M | $1.19M | $1.19M |
| Investing Cash Flow | ($2.88M) | ($4.15M) | ($1.03M) | ($1.29M) | ($3.48M) | ($3.48M) |
| Financing Cash Flow | $3.28M | $4.37M | ($537.0K) | ($601.0K) | ($432.0K) | ($432.0K) |
| CapEx | $2.80M | $3.97M | $749.0K | $1.21M | $2.49M | $1.93M |
| Free Cash Flow | $19.15M | ($3.28M) | $176.0K | $1.16M | ($1.30M) | ($738.0K) |
Ratios
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 37.8% | 30.8% | - | 34.2% | 31.0% | 33.3% |
| Operating margin | 16.1% | 1.8% | - | -1.7% | -3.1% | 0.0% |
| EBITDA margin | 18.7% | 4.9% | - | 2.9% | 0.8% | 2.5% |
| Net margin | 16.8% | 4.4% | - | -2.0% | -3.4% | 0.0% |
| Free cash flow margin | 25.1% | -6.4% | - | 3.5% | -3.4% | -2.2% |
| FCF / Net income | 1.49 | -1.45 | 0.82 | -1.72 | 1.00 | -56.77 |
| R&D / Revenue | 0.1% | 0.2% | - | 0.3% | - | - |
| SG&A / Revenue | 20.6% | 27.5% | - | 33.5% | 32.0% | 32.4% |
| Effective tax rate | 10.3% | -231.3% | 44.3% | - | - | 64.9% |
| Return on assets | 17.1% | 4.2% | 0.6% | -2.0% | -3.8% | 0.0% |
| Return on equity | 27.6% | 7.7% | 0.8% | -2.7% | -5.1% | 0.1% |
| Return on invested capital | 22.1% | 2.8% | 0.9% | -1.7% | - | - |
| Liquidity | ||||||
| Current ratio | 2.63 | 1.83 | 2.29 | 2.71 | 2.61 | 4.06 |
| Quick ratio | 2.27 | 1.41 | 1.83 | 2.05 | 1.98 | 3.36 |
| Cash ratio | 1.62 | 0.41 | 1.52 | 2.53 | 0.72 | 2.21 |
| Leverage | ||||||
| Debt / Equity | 0.07 | 0.12 | 0.04 | 0.06 | 0.08 | - |
| Debt / Assets | 0.04 | 0.06 | 0.03 | 0.04 | 0.06 | - |
| Debt / EBITDA | 0.23 | 1.39 | 0.45 | 1.49 | 6.72 | - |
| Interest coverage | 63.4x | 7.2x | 5.1x | -6.1x | - | - |
| Equity multiplier | 1.62 | 1.83 | 1.38 | 1.32 | 1.36 | 1.26 |
| Liabilities / Assets | 0.38 | 0.45 | 0.28 | 0.24 | 0.27 | 0.21 |
| Efficiency | ||||||
| Asset turnover | 1.01 | 0.94 | - | 1.00 | 1.11 | 1.11 |
| Inventory turnover | 7.77 | 6.28 | 7.62 | 7.21 | 6.43 | 5.68 |
| Days sales outstanding | 47d | 84d | - | 70d | 72d | 64d |
| Days inventory outstanding | 47d | 58d | 48d | 51d | 57d | 64d |
| Days payable outstanding | 22d | 34d | 37d | 19d | 24d | 27d |
| Cash conversion cycle | 71d | 108d | - | 101d | 105d | 101d |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 49.4% | - | - | -12.6% | 14.4% | 8.0% |
| Revenue CAGR (3y) | 31.8% | 10.2% | - | 2.6% | 12.9% | 15.7% |
| Revenue CAGR (5y) | 18.0% | 10.6% | - | 9.2% | 11.9% | - |
| Gross profit growth (YoY) | 83.4% | 18.8% | 16.4% | -3.7% | 6.5% | 1.1% |
| Operating income growth (YoY) | 1251.9% | 103.6% | - | 51.4% | - | -99.6% |
| Net income growth (YoY) | 467.9% | 958.9% | - | 48.0% | - | -98.9% |
| EPS growth (YoY) | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | -84.8% | - | -75.9% | 56.0% |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | 57.5% | 13.2% | 3.8% | -0.4% | 6.1% | 1.1% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-06-30.
Product / service
$76.42M totalMailbacks$49.62M · 64.9%
Route Based Pickup Services$13.68M · 17.9%
Unused Medications$8.16M · 10.7%
Product And Service Other$4.40M · 5.8%
Third Party Treatment Services$570.0K · 0.7%
Stability scores
Altman Z′
FY 2021 · bankruptcy risk
2.61
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2021 · 9-point quality
8/9
Strong
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✓Current ratio improved
- ✗No share dilution
- ✓Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Hazardous Waste Management
Comparing SHARPS COMPLIANCE CORP against the 5 most active filers in the same SIC group.